|
|
|
Feed Submission If you'd like OHCNetwork Health News to link to your health news or blog from this category (Schizophrenia - Mental Diseases - Diseases and Conditions), please submit your RSS or XML feed to OHCNetwork Health News. Contact information is available here. |
Health News >> Diseases and Conditions >> Mental Diseases >> Schizophrenia
Schizophrenia News
Medindia Health News - Schizophrenia
Australian Mental Health Research is on the verge of path breaking news that suggests possible links between Vitamin DMedindia Health News - Schizophrenia
Professor William Honer and researchers have reported the results of the study in New England Journal of Medicine in whiMedindia Health News - Schizophrenia
The possibility of cannabis use leading to schizophrenia has been ruled out according to a latest report from the GovernMedindia Health News - Schizophrenia
In US a team of researcher from the university of Texas Southwestern Medical Center in Dallas reported that the gene NR1Medindia Health News - Schizophrenia
Time and over again, debates have been raised against the link between drug abuse and Schizophrenia. A recent study doneMedindia Health News - Schizophrenia
In what can be considered as an important breakthrough in our still limited understanding of major mental illness, reseaMedindia Health News - Schizophrenia
Researcher Dr. Wan Lian Chua, Psychiatrist, Bradford District Care Trust had said that estrogen therapy to women with ScMedindia Health News - Schizophrenia
There is a close relationship between language functioning and schizophrenia, and verbal memory is a legitimate and impoMedindia Health News - Schizophrenia
Researchers from University of New South Wales may be one of the first scientists to develop a tool for diagnosing schizMedindia Health News - Schizophrenia
Babies born during famine face the risk of developing schizophrenia later in life, says a study in China.
DMedindia Health News - Schizophrenia
After studying around 700,000 people researchers say dads who have children at an older age may increase their child's r
Medindia Health News - Schizophrenia
A new study suggests exposure to influenza while in the womb may put infants at risk of developing schizophrenia later o
Medindia Health News - Schizophrenia
A history of gluten intolerance, a hereditary disease that affects thousands of Americans, appears to be a risk factor f
Medindia Health News - Schizophrenia
Researchers have found that two overlapping genes responsible for bipolar disorder. In previous study researchers found
Medindia Health News - Schizophrenia
Researchers from Boston Healthcare System and Harvard University observed that anomalies in the part of the brain respon
Medindia Health News - Schizophrenia
According to Japanese researchers, genetic abnormalities bound with marijuana-activated brain chemicals appear connected
Medindia Health News - Schizophrenia
Two new studies have identified genetic activity that appears to be associated with schizophrenia, a serious brain disor
Medindia Health News - Schizophrenia
Many scientists have drawn another blank in their search for a universally applicable genetic explanation for schizophre
Medindia Health News - Schizophrenia
Scientists have developed a computer test which they say has proved 100% precise in early tests. The computer programme
Medindia Health News - Schizophrenia
According to researchers linking childhood sexual abuse and schizophrenia will further confuse patients of the mental il
Schizophrenia News From Medical News Today
In one of the first instances of targeted drug design in psychiatric treatment, University of Pittsburgh researchers have found an experimental agent that shows promise in addressing working memory impairments that occur in the schizophrenia. The study breaks new ground in the strategy used to develop new pharmacological treatments for schizophrenia, explained David Lewis, M.D.
Schizophrenia News From Medical News Today
To help raise awareness about discrimination against people with mental illness, the Wyoming Department of Health is inviting residents with relevant personal experience to participate in a December 3 public hearing in Cheyenne.
Schizophrenia News From Medical News Today
Physicians and policy-makers know that drugs are frequently prescribed to treat certain diseases despite a lack of FDA approval - a practice known as off-label prescribing. Yet they say the problem is so big they don't know how to begin tackling it. But a potential game plan now exists.
Schizophrenia News From Medical News Today
Schering-Plough Corporation (NYSE: SGP) revealed top-line results of a long-term Phase III clinical study of its psychopharmacologic agent SAPHRIS(TM) (asenapine) demonstrating efficacy and safety in preventing relapse of schizophrenia. In this trial, asenapine was statistically significantly more effective than placebo in preventing relapse, as measured by the primary endpoint of the trial estimated through Kaplan-Meier curves.
Schizophrenia News From Medical News Today
Memory Pharmaceuticals Corp. (Nasdaq: MEMY) announced that it has achieved the enrollment goal for its Phase 2 trial of R3487/MEM 3454, its lead alpha-7 nicotinic receptor agonist, in cognitive impairment associated with schizophrenia (CIAS). The Company has randomized 212 patients in the Phase 2 trial, triggering a $5.0 million payment from its partner Roche. Memory Pharmaceuticals expects to report top-line results from the trial by the end of April 2009.
Schizophrenia News From Medical News Today
New research has traced elevated levels of a specific compound in the brain to problem-solving deficits in patients with schizophrenia. The finding suggests that drugs used to suppress the compound, called kynurenic acid, might be an important supplement to antipsychotic medicines, as these adjuncts could be used to treat the disorder's most resistant symptoms - cognitive impairments.
Schizophrenia News From Medical News Today
Internationally renowned experts in schizophrenia and other psychotic disorders, researchers and clinicians, patients and their families and friends, will gather in Pittsburgh to discuss the latest in research and clinical advances at the 25th Annual Pittsburgh Schizophrenia Conference to be held Friday, Nov. 21 at the Sheraton Station Square, Pittsburgh.
Schizophrenia News From Medical News Today
Lipocine Inc., a specialty pharmaceutical company that uses clinically validated proprietary technologies to address key unmet drug delivery and therapeutic needs, today announced the successful completion of a clinical study that establishes feasibility of the first once-a-day dosing product for Ziprasidone, a leading treatment for schizophrenia and bipolar disorder. - Schizophrenia affects 1% of the population and bipolar disorder affects 5.7M adults in the US*.
Schizophrenia News From Medical News Today
Emory University in Atlanta is playing a key role in the largest, most comprehensive study ever funded by the National Institute of Mental Health (NIMH) of adolescents and young adults at risk for developing a psychotic disorder. The five-year, $25-million study joins the resources of Emory and seven other major research universities, with the goal of identifying more precise predictors for psychosis, and a better understanding of the neural mechanisms involved.
Schizophrenia News From Medical News Today
A collaborative study led by investigators from Massachusetts General Hospital (MGH) is giving what may be the first look at how interactions between genes underlie a key symptom of schizophrenia, impaired working memory. Functional imaging studies reveal how a combination of common variants in two genes is associated with reduced activity of important brain structures in schizophrenia patients but not in normal controls.
Schizophrenia News From Medical News Today
Research from the University of Pittsburgh could expand the options for controlling schizophrenia by identifying a brain region that responds to more than one type of antipsychotic drug. The findings illustrate for the first time that the orbitofrontal cortex could be a promising target for developing future antipsychotic drugs - even those that have very different mechanisms of action. The study will be published during the week of Nov.
Schizophrenia News From Medical News Today
Psychosis Rates Higher In Immigrant Groups In LondonA higher risk of psychosis is found in first and second generation immigrants to the United Kingdom, in comparison to white British people, according to a report released on November 3, 2008 in Archives of General Psychiatry, one of the JAMA/Archives journals.
Schizophrenia News From Medical News Today
Researchers examining the occurrence of psychoses among migrant groups have shown a raised incidence for all black and ethnic minority subgroups compared with white British counterparts, and reveal that the risk of psychoses for first and second generations varies by ethnicity.
Schizophrenia News From Medical News Today
Both first- and second-generation immigrants to the United Kingdom appear to have a higher risk of psychoses than white British individuals, according to a report in the November issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Schizophrenia News From Medical News Today
Patients with schizoaffective disorder receiving paliperidone extended release tablets (paliperidone ER) for six weeks showed a significant improvement in their symptoms, according to a new study presented today at the U.S. Psychiatric & Mental Health Congress in San Diego, Calif.(1) In addition, safety findings were similar to published studies of paliperidone ER in the treatment of schizophrenia.
Schizophrenia News From Medical News Today
Children who are exposed to physical abuse or domestic violence are at greater risk of having psychotic experiences when they reach their teenage years, according to new research. The study, which is published in the November issue of the British Journal of Psychiatry, examined 211 adolescents aged between 12 and 15 years and living in Dublin. 117 of the adolescents had already been identified as being at high risk of having mental health problems.
Schizophrenia News From Medical News Today
About 1.4 million hospitalizations in 2006 involved patients who were admitted for a mental illness, while another 7.1 million patients had a mental disorder in addition to the physical condition for which they were admitted, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. The 8.5 million hospitalizations involving patients with mental illness represented about 22 percent of the overall 39.5 million hospitalizations in 2006.
Schizophrenia News From Medical News Today
Is schizophrenia a disorder of glutamate hyperactivity or hypoactivity? While the predominant hypothesis for many years was that schizophrenia was a glutamate deficit disorder, there is growing evidence of glutamate hyperactivity as well. The study by Karlsson et al., appearing in the November 1st issue of Biological Psychiatry, reinforces this point with new data about the impact of deleting the gene for the glutamate transporter EAAT1.
Schizophrenia News From Medical News Today
Patients suffering from psychosis are at elevated risk of suicide, with at least 20% of making a suicide attempt in their lifetime. Factors associated with suicidality in early psychosis include depression, hopelessness and negative psychotic symptoms. In this study, researchers examined the rates of suicidal ideation and suicide attempts in all patients diagnosed with first episode psychosis in a defined catchment area over a 2-year period.
Schizophrenia News From Medical News Today
This study investigates the duration of untreated psychosis (DUP) in relation to demographic, illness and methodological factors using a systematic review of published studies of DUP and available DUP distributions. The results showed that DUP is shorter in samples that include patients with affective-psychosses, and longer in samples with a greater proportion of patients with schizophrenia.
Schizophrenia News From Medical News Today
This study explores the burden levels experienced by families of patients diagnosed with early psychotic illness. Participating family members were assessed using a 'Family Experiences Interview Schedule' which covered both objective and subjective burdens. Examples of objective burdens included increased financial burden and disruption of routine, while subjective burdens included emotional strains such as worry, anger and resentment.
Schizophrenia News From Medical News Today
Many of the structural and neurochemical features of schizophrenia are present long before the full syndrome of schizophrenia develops. What processes tip the balance between the ultra-high risk states and the development of schizophrenia? One candidate mechanism is cerebral inflammation, studied by Dr. Bart van Berckel and colleagues in the November 1st issue of Biological Psychiatry.
Schizophrenia News From Medical News Today
Complications during pregnancy and birth, such as birth hypoxia - the shortage of oxygen in the body - are associated with an increased risk for schizophrenia. However, it is not clear why hypoxia increases the risk for schizophrenia. The November 1st issue of Biological Psychiatry includes an article by researchers who show that the presence of a specific indicator of fetal distress following hypoxia was more likely to be present among people who later develop schizophrenia.
Schizophrenia News From Medical News Today
A lack of specific brain receptors has been linked with schizophrenia in new research by scientists at Newcastle University. In work published in the Proceedings of the National Academy of Sciences, the team has found that NMDA receptors are essential in modifying brain oscillations - electrical wave patterns - which are altered in patients with schizophrenia.
Schizophrenia News From Medical News Today
Schering-Plough Corporation (NYSE: SGP) announced that its novel psychopharmacologic agent asenapine has met the primary endpoint in a long-term schizophrenia relapse prevention trial. Asenapine, which is administered as a fast-dissolving sublingual tablet, is a psychopharmacologic compound with a unique human receptor signature.
| ||||||||||||||||||
| ||||||||||||||||||